Pullman, WA—New research looks to provide government regulators with new tools to identify specific strains of hemp and cannabis, allowing them to address a range of concerns regarding marijuana, hemp, and cannabidiol (CBD), according to report on Science Daily.
The researchers analyzed genetic sequences from nine commercial cannabis strains and found distinct gene networks, each of which orchestrate production of cannabinoids and terpenes. This analytical method, the release says, can be used to delineate between cannabis and hemp; can identify the terpene that makes the well-known smell of plant, and provide a path to breed a similar strain with a better smell; and can help test the health claims of cannabidiol and the entourage effect between cannabinoids.
The study, published in Plant Physiology, was headed by Mark Lange, a professor at Washington State University’s Institute for Biological Chemistry and all material was handled by EVIO Labs.
“You need to know what you’re selling,” Lange said of the emerging market. “You can’t just call it something and then that’s good. We need to be very clear that this is the cannabinoid profile that is associated with, say, Harlequin—it has a specific cannabinoid profile, a specific terpenoid profile, and that’s what it is. If it has a different name, then it should have a different profile. Currently you can do whatever you want.”